Identification of alkynyl nicotinamide HSN748 as a RET solvent-front mutant inhibitor with intracranial efficacy is a research paper published in RSC Medicinal Chemistry (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA273168
National Institutes of Health
Grant: R01CA242845
National Institutes of Health
Grant: P30CA225520
National Institutes of Health
Grant: P30GM154635
National Institutes of Health
Grant: R01CA258546
National Institutes of Health
Grant: P30CA023168
National Institutes of Health
Grant: 5R01CA242845-04
Blocking tumor progression in therapy-responsive RET aberration-associated cancer
National Institutes of Health
Grant: 3P30CA023168-20S1
CORE--DNA ANALYSIS
National Institutes of Health
Grant: 1R01CA273168-01
Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold
National Institutes of Health
Grant: 5R01CA258546-02
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
National Institutes of Health
Grant: 3P30CA225520-06S4
Stephenson Cancer Center - Cancer Center Support Grant
Presbyterian Health Foundation
Oklahoma Tobacco Settlement Endowment Trust
University of Oklahoma Health Sciences Center
Fields of Study
Keywords